SCHEMBL7123387

SCHEMBL7123387

CCOC(=O)NC(=S)Nc1ccc(-c2ccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
ALDH1A1 P00352 2/20 0.61
HTT P42858 1/20 0.61
PPARG P37231 8/20 0.55
KMT2A Q03164 5/20 0.55
RORC P51449 5/20 0.55
MEN1 O00255 4/20 0.55
CYP3A4 P08684 2/20 0.55
MAPK1 P28482 2/20 0.55
LMNA P02545 2/20 0.55
TP53 P04637 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
PKM P14618 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
CYP2C19 P33261 1/20 0.55
THPO P40225 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129307 0.90 PPARG (0.57) MAPTSMN1; SMN2ALDH1A1HTTPPARG
SCHEMBL7123352 0.86 KMT2A (0.52) MAPTSMN1; SMN2ALDH1A1HTTPPARG
SCHEMBL7123730 0.84 KMT2A (0.65) MAPTSMN1; SMN2ALDH1A1HTTPPARG
SCHEMBL7121705 0.82 RORC (0.80) MAPTSMN1; SMN2PPARGKMT2ARORC
SCHEMBL7122936 0.81 RORC (0.80) MAPTSMN1; SMN2ALDH1A1HTTPPARG
SCHEMBL7119782 0.81 MAPT (0.68) MAPTSMN1; SMN2ALDH1A1HTTPPARG
SCHEMBL27589534 0.81 RORC (0.78) MAPTSMN1; SMN2ALDH1A1HTTPPARG
SCHEMBL7119689 0.81 SMN1; SMN2 (0.64) MAPTSMN1; SMN2ALDH1A1PPARGKMT2A
SCHEMBL7130312 0.81 PPARG (0.63) MAPTSMN1; SMN2PPARGKMT2ARORC
SCHEMBL7126984 0.80 PPARG (0.66) MAPTSMN1; SMN2ALDH1A1HTTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MAPT 4391/4885SMN1; SMN2 3743/4885ALDH1A1 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.